425: CoreWeave Updates on Core Scientific Acquisition

CoreWeave, Inc. provided an update on its proposed acquisition of Core Scientific, Inc., detailing SEC filing statuses and urging investor review of transaction documents.

Summary

• CoreWeave, Inc. posted a communication on its LinkedIn account on October 7, 2025, regarding its proposed acquisition of Core Scientific, Inc.
• CoreWeave filed a registration statement on Form S-4 (No. 333-289742) with the SEC on August 20, 2025, to register shares of common stock and warrants for the transaction.
• The Form S-4 was declared effective by the SEC on September 26, 2025, and CoreWeave filed the related prospectus on the same date.
• Core Scientific filed the definitive proxy statement with the SEC on September 26, 2025.
• The Prospectus and the Proxy Statement were first mailed to stockholders of Core Scientific on or about September 26, 2025.
• Investors and security holders of both companies are urged to read the Form S-4, Proxy Statement, Prospectus, and any other relevant SEC documents carefully before making any voting or investment decisions.

Sentiment

Score: 6

Explanation: The filing provides a procedural update on an ongoing acquisition, indicating progress with SEC filings. However, it also includes an extensive list of risks associated with the transaction, leading to a neutral-to-slightly-positive sentiment, as the process is moving forward but with acknowledged uncertainties.

Positives

• The Form S-4 registration statement for the proposed acquisition was declared effective by the SEC on September 26, 2025, indicating regulatory progress for the transaction.
• The related Prospectus and definitive Proxy Statement have been filed and mailed to Core Scientific stockholders, moving the acquisition process closer to a stockholder vote.

Risks

• Uncertainty regarding the completion of the proposed transaction on anticipated terms, or at all, and the timing of completion, including obtaining Core Scientific stockholder approval.
• Uncertainty in the value of the consideration that Core Scientific stockholders would receive due to fluctuations in the market price of CoreWeave common stock.
• The possibility that anticipated benefits of the proposed transaction, such as tax treatment, synergies, and economic performance, will not be realized or not within the expected time period.
• Challenges in the ability of CoreWeave and Core Scientific to successfully integrate their businesses and achieve anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction that could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.
• The risk that disruptions from the proposed transaction will harm CoreWeave's or Core Scientific's business, including current plans and operations.
• Diversion of management's time and attention to transaction-related issues.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Impacts from rating agency actions and CoreWeave's and Core Scientific's ability to access shortand long-term debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the proposed transaction.
• Certain restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue certain business opportunities or strategic transactions.
• Risks from acts of terrorism or outbreak of war, hostilities, civil unrest, attacks, and other political or security disturbances.
• Dilution caused by CoreWeave's issuance of additional shares of its securities in connection with the proposed transaction.
• The possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events.
• The impacts of pandemics or other public health crises, including the effects of government responses on people and economies.
• Global or regional changes in the supply and demand for power and other market or economic conditions that impact demand and pricing.
• Changes in technical or operating conditions, including unforeseen technical difficulties.
• Development delays at CoreWeave and/or Core Scientific data center sites, including any delays in the conversion of such sites from crypto mining facilities to high-performance computing sites.

Future Outlook

The proposed transaction aims for the consummation of the acquisition, successful integration of businesses, and achievement of anticipated synergies and value creation. The combined company expects to manage, expand, and grow its operations, though these outcomes are subject to significant risks and uncertainties as detailed in the forward-looking statements.

Industry Context

The proposed acquisition involves companies operating in the artificial intelligence, power, data center, and crypto mining industries. The transaction reflects ongoing strategic shifts within these sectors, particularly the conversion of crypto mining facilities to high-performance computing sites, aligning with the growing demand for AI infrastructure and data processing capabilities.

Legal Proceedings

• Potential litigation relating to the proposed transaction could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.

Stakeholder Impact

• Shareholders of Core Scientific will receive CoreWeave common stock and warrants, with the value of consideration subject to market fluctuations. They are urged to review transaction documents for voting decisions.
• Shareholders of CoreWeave will experience dilution due to the issuance of additional shares and warrants for the acquisition.
• Employees of both companies may be impacted by the integration of businesses post-acquisition.
• Business relationships of both companies may experience adverse reactions or changes resulting from the announcement or completion of the transaction.
• Creditors may be impacted by rating agency actions and the combined company's ability to access debt markets.

Next Steps

• Core Scientific stockholders need to approve the proposed transaction through a vote.
• CoreWeave and Core Scientific will proceed with the integration of their businesses post-acquisition.
• The combined company will aim to achieve anticipated synergies and value creation from the merger.
• Further SEC filings and communications are expected as the transaction progresses towards completion.

Key Dates

Recommendation

This filing is a procedural update on an ongoing acquisition, confirming that necessary SEC documents (Form S-4, Prospectus, Proxy Statement) have been filed, declared effective, and mailed to shareholders. It does not contain new financial performance data but highlights numerous risks associated with the transaction's completion, integration, and realization of benefits. Investors should hold and carefully review the detailed information in the Form S-4, Proxy Statement, and Prospectus to assess the full implications and risks before making any investment or voting decisions.

Keywords

CoreWeave, Core Scientific, Acquisition, Merger, SEC Filing, Form 425, Form S-4, Proxy Statement, Prospectus, Artificial Intelligence, Data Center, Crypto Mining, Corporate Governance, Investment